Wanru X. Ma - Publications

Advancements in Blood Group Genotyping Technology and Clinical Applications.

Journal: Clinical chemistry

Published: October 08, 2025

The linear ANRIL transcript P14AS regulates the NF-κB signaling to promote colon cancer progression.

Journal: Molecular medicine (Cambridge, Mass.)

Published: June 25, 2023

Downregulated CDH3 is correlated with a better prognosis for LUAD and decreases proliferation and migration of lung cancer cells.

Journal: Genes & genomics

Published: May 04, 2023

Corrigendum: P14AS upregulates gene expression in the CDKN2A/2B locus through competitive binding to PcG protein CBX7.

Journal: Frontiers in cell and developmental biology

Published: October 06, 2022

P14AS upregulates gene expression in the CDKN2A/2B locus through competitive binding to PcG protein CBX7.

Journal: Frontiers in cell and developmental biology

Published: July 13, 2022

Models to predict the probability for intraoperative RBC transfusion during lumbar spinal stenosis and femoral fracture surgeries in aged patients.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: July 08, 2021

Efficacy of stellate ganglion block in perioperative period of patients with chronic sinusitis and hypertension

Journal: Zhonghua yi xue za zhi

Published: September 07, 2020

Characterization of novel LncRNA P14AS as a protector of ANRIL through AUF1 binding in human cells.

Journal: Molecular cancer

Published: September 26, 2019

Analysis of risk factors associated central venous catheter-related thrombosis in patients undergoing abdominal operation

Journal: Zhonghua yi xue za zhi

Published: September 13, 2019

Targeting immunotherapy for bladder cancer by using anti-CD3 × CD155 bispecific antibody.

Journal: Journal of Cancer

Published: September 14, 2018

The bispecific anti-CD3 × anti-CD155 antibody mediates T cell immunotherapy for human prostate cancer.

Journal: Investigational new drugs

Published: August 16, 2018

Targeting immunotherapy for bladder cancer using anti-CD3× B7-H3 bispecific antibody.

Journal: Cancer medicine

Published: April 02, 2018